Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/12/2025

Management and Treatment for Genetic Lung Blebs

Clinical Significance and Pathophysiology

  • Subpleural blebs and bullae are found in up to 90% of primary spontaneous pneumothorax cases at thoracoscopy or thoracotomy and in up to 80% of cases on CT scanning, suggesting they play a significant role in pneumothorax pathogenesis 1
  • Paraseptal emphysema occurs close to connective tissue septae and usually leads to blebs on the lung surface which predispose to pneumothorax or to giant bullae within the lung substance 2
  • Genetic factors significantly increase susceptibility to lung abnormalities, with multiple common and rare genetic variants associated with disease risk 3

Diagnostic Approach

  • In patients with haemoptysis or suspected blebs, CT scan images can help localize the area prior to bronchoscopy 4

Treatment Options

  • For patients with small, asymptomatic blebs without history of pneumothorax, observation may be appropriate 1
  • Strong emphasis should be placed on smoking cessation, as smoking significantly increases the risk of pneumothorax in those with genetic lung blebs 1

Genetic Considerations

  • Genetic testing should be offered to patients with suspected genetic predisposition to lung blebs, particularly those with family history of pneumothorax or other manifestations of telomere-related disorders 3
  • First-degree relatives of affected individuals should be offered genetic counseling regarding potential risks and benefits of genetic testing 3

Monitoring and Follow-up

  • Patients with genetic lung blebs who have undergone treatment should have regular follow-up with imaging to monitor for recurrence 1
  • Patients with telomere-related disorders should be monitored for other manifestations including pulmonary fibrosis, liver dysfunction, and bone marrow abnormalities 5